Most investors meet a company after it becomes famous.
The stock is already listed. The business has already attracted institutional attention. The valuation has already moved. And the easy part of the growth story may already be priced in.
The Carnelian Private Growth & Innovation Fund is built around a very different idea: get closer to the company before the public-market spotlight arrives.
But there is a twist.
This is not simply a traditional private-equity fund waiting years for an exit. Carnelian combines growth-stage private investments, pre-IPO opportunities and PIPE investments in listed companies under one Growth-to-PIPE strategy.
That creates an unusual proposition: invest across the journey from private growth to public-market opportunity.
The strategy targets INR 2,000 crore, including an INR 800 crore green-shoe option, and aims to build a concentrated portfolio of around 15–20 companies.
For investors, however, the headline numbers are only half the story. The more important question is whether this strategy can identify tomorrow's market leaders before the market starts paying attention.
The Big Idea: Don't Chase the IPO. Find the Business Before It
India's public markets contain thousands of listed companies. But a much larger opportunity set exists before a business reaches the stock exchange.
Carnelian's investment thesis focuses on this private-market pipeline.
The strategy highlights approximately 3,000 PE/VC-backed companies that have collectively attracted more than INR 7 lakh crore of capital. It also identifies 1,900+ potential future IPO candidates growing at 25% or more with positive EBITDA.
That is where the strategy wants to operate.
Instead of waiting for an IPO announcement and then deciding whether the valuation looks attractive, Carnelian seeks to enter companies earlier in their growth journey.
The objective is straightforward:
Find high-quality businesses before they become obvious to everyone else.
That sounds simple.
It isn't.
Private-market investing involves limited liquidity, imperfect information, changing valuations and considerable execution risk. The real differentiator therefore lies in how businesses are selected, valued, monitored and eventually exited.
That is where Carnelian's investment frameworks come into play.
What Makes the Growth-to-PIPE Strategy Different?
Traditional private-equity investing can involve committing capital to businesses and waiting several years for value creation and exits.
Carnelian takes a broader approach.
Its Growth-to-PIPE construct combines three investment sleeves:
1. Growth Equity
Around 50–60% of the portfolio is intended for growth-stage businesses.
These companies are already operating businesses but are positioned for accelerated expansion. Carnelian looks for opportunities where earnings growth, ownership and board access can potentially contribute to returns.
The indicative holding period is 4–5 years.
This is intended to be the portfolio's primary long-term value-creation engine.
2. Late-Stage and Pre-IPO
Around 20–25% is targeted towards late-stage and pre-IPO investments.
These businesses are closer to the public markets, potentially creating a shorter path towards liquidity.
The indicative holding period is 6 months to 2 years.
The idea is to capture PE-style investment opportunities before a company transitions into the public market.
3. PIPE
Another 20–25% is intended for PIPE opportunities.
PIPE stands for Private Investment in Public Equity.
Here, the strategy looks for listed companies where market dislocations or discounted entry valuations can create attractive investment opportunities.
The indicative holding period is 2–3 years.
Carnelian positions PIPE as its DPI engine, with the broader strategy seeking to create multiple potential routes for returning capital.
The stated endeavour is to begin returning invested capital from the fifth year onwards.
So the strategy isn't betting on just one exit route.
It is attempting to build several.
The Carnelian Private Growth Is Designed to Be Concentrated — Not Crowded
The fund targets approximately 15–20 portfolio companies.
That is important.
A portfolio with hundreds of investments can dilute the impact of individual winners. Carnelian instead aims for a focused set of businesses where the investment team can potentially contribute capital, governance and strategic support.
The indicative deal size is INR 100–250 crore.
The strategy also aims to diversify across four or more sectors.
The intended portfolio therefore sits somewhere between concentration and diversification:
Enough companies to manage individual-company risk, but few enough to maintain meaningful investment conviction.
Co-investment opportunities may also be available to select investor classes, potentially allowing eligible investors to take larger exposure to high-conviction opportunities.
Four Sectors Where Carnelian Sees India's Next Growth Wave
Carnelian's core sector focus spans manufacturing, pharma and healthcare, consumption and technology.
Manufacturing: India's China+1 Moment
Precision engineering, defence and aerospace are among the targeted themes.
The structural thesis is driven by China+1, Make in India and PLI-linked manufacturing opportunities.
The bigger story is supply-chain diversification.
As global companies reconsider where products are manufactured, Indian businesses with the right capabilities could potentially move up the value chain.
Pharma and Healthcare: Beyond Traditional Pharma
The healthcare allocation covers areas such as:
- CDMO
- APIs
- Domestic pharmaceuticals
- Healthcare services
India's growing healthcare demand provides one structural driver, while global supply-chain diversification provides another.
Consumption: The Income Effect
Rising incomes, changing consumer preferences and India's demographic profile create a broad consumption opportunity.
The strategy looks beyond one specific consumer category and focuses on businesses benefiting from increasing consumer spending.
Technology: AI, Energy Transition and Recycling
Technology is another key focus.
Carnelian highlights AI beneficiaries, energy transition and recycling as areas where technology could solve large-scale problems.
The investment philosophy is not simply about buying technology companies.
It is about identifying businesses where technology can create scalable competitive advantages.
The strategy can also invest opportunistically outside these four sectors, including areas such as financials.
The Carnelian Private Growth and Inovation Doesn't Start With a Spreadsheet. It Starts With the Entrepreneur.
One of the more important parts of Carnelian's investment process is its emphasis on founders and management teams.
The strategy looks for entrepreneurs demonstrating:
- Passion for the business
- Operating capability
- Scalability
- Strong governance
- Integrity
- Risk awareness
- Meaningful personal capital invested in the business
This matters because private-market investing is often a bet on people as much as it is a bet on financial statements.
A great market cannot rescue poor execution indefinitely.
A strong balance sheet cannot compensate forever for weak governance.
And a compelling growth narrative means little if management cannot execute.
Carnelian therefore combines business assessment with forensic analysis before committing capital.
MAGIC: Looking for the Moment Before the Market Wakes Up
Carnelian uses its MAGIC framework to identify businesses approaching a potential catalytic inflection point.
The framework looks for several ingredients.
Earnings Growth
The strategy targets businesses capable of generating approximately 20–25% earnings growth through business performance.
Re-rating Potential
Another potential return driver is 5–10% re-rating through multiple expansion.
The thesis is that earnings growth alone may not be enough.
The market must eventually recognise the quality of that growth.
Unique Business Models
Carnelian seeks businesses with differentiated models that can create defensibility and reduce direct comparability.
Early Theme Identification
Getting into a theme early can matter enormously in private markets.
By the time the theme becomes mainstream, valuations may already reflect the opportunity.
Scarcity Premium
Some businesses have limited public-market comparables.
That scarcity can potentially create a premium when investors begin seeking exposure to the same category.
Governance Transformation
Family-owned companies institutionalising their governance can potentially create another value-creation trigger.
Structural Catalysts
The strategy also considers catalysts such as:
- Macro tailwinds
- Structural industry shifts
- New products
- Completed capex
- R&D-backed differentiation
The underlying idea is simple:
Don't merely find a good company. Find a good company approaching a moment when its economics could change faster than the market expects.
CLEAR: Because Great Growth Can Hide Ugly Numbers
Growth is attractive.
But growth without cash flow, clean accounting or sound governance can become an expensive mistake.
Carnelian's CLEAR forensic framework is designed to investigate what sits beneath reported financial performance.
Cash Flow
The framework examines earnings conversion and distinguishes reported cash flows from more stable underlying cash generation.
Liability
It looks beyond headline debt to identify true liabilities, contingent obligations and potential future earnings impacts.
Earnings Quality
Reported profits are examined against economic profit and potentially discretionary components.
Asset Quality
The analysis considers core versus non-core assets and the creation of intangible value.
Related Parties and Governance
Related-party transactions, complicated corporate structures and off-balance-sheet arrangements are examined for potential risks.
The purpose is not to make the investment process sound complicated.
It is to answer a brutally practical question:
Are the numbers telling the whole story?
Carnelian Wants to Be More Than a Cheque
Private-market investing is not always about writing a cheque and waiting.
Carnelian's value-enhancement approach can involve support across several areas, including:
- IPO positioning
- Listing narratives
- Investor communication
- KPI tracking
- Capital efficiency
- M&A
- Capital raising
- Expansion opportunities
- Management incentives
- CXO hiring
- Governance
That creates a more active investment model.
The potential benefit is that the investment manager can participate in the company's development rather than simply monitor quarterly performance.
Of course, operational involvement does not eliminate business risk.
It simply creates another potential lever for value creation.
The Fund's Size Is Ambitious
The target corpus is INR 2,000 crore, including an INR 800 crore green-shoe option.
The sponsor commitment is stated at INR 100 crore+.
The fund's size is relevant because the strategy is designed for mid-sized private-market opportunities.
Carnelian describes this segment as a structural whitespace where funds can compete for opportunities in the INR 100–500 crore range, potentially combining negotiated private-market entry with IPO partnership capabilities.
The fund's indicative investment size of INR 100–250 crore fits directly into this positioning.
The Catch: Your Money Does Not All Go In on Day One
This is one of the most important things investors need to understand.
The Carnelian Private Growth & Innovation fund follows a commitment-based structure.
Investors contribute 10% upfront.
The remaining capital can then be drawn down as investment opportunities are approved.
That means an investor should not look at the initial contribution alone.
The actual financial commitment can be substantially larger.
The commitment period is 36 months from first close, with a possible one-year extension.
Investors therefore need enough liquidity to meet future capital calls.
A private-market fund can find a fantastic investment opportunity at exactly the wrong time for an investor who has already stretched their liquidity.
Capital-call planning matters.
The Investment Horizon Is Long — Really Long
The stated fund tenure is 6 years and 9 months after first close.
There is a possible extension of up to two years.
The commitment period itself can also be extended by one year.
This means investors should think in terms of a multi-year private-market commitment, not a conventional market investment that can be exited whenever sentiment changes.
The fund seeks to return invested capital from the fifth year onwards, but this is an endeavour rather than a guaranteed outcome.
Private-company exits depend on company performance, buyer appetite, IPO conditions, market valuations and transaction execution.
Carnelian Fund Fees: The Larger the Commitment, the Lower the Management Fee
The fee structure varies by commitment size.
For commitments between INR 1 crore and INR 4.99 crore, the management fee is 2.00% per annum, with an additional return component of 20.00%.
For commitments between INR 5 crore and INR 14.99 crore, the management fee falls to 1.75% per annum, while the additional return component is 17.50%.
For commitments above INR 15 crore, the management fee is 1.50% per annum, with an additional return component of 15.00%.
Management fees are charged on the aggregate capital commitment.
The Carnelian Private Growth & Innovation fund also has a 15% per annum pre-tax hurdle rate, with catch-up applicable.
Investors should therefore assess the economics based on the complete fee and distribution structure rather than focusing only on the headline management fee.
Who Is This Fund Really For?
This strategy is not designed for an investor looking for daily liquidity.
It is better suited to investors who understand private-market investing and can tolerate:
- Long holding periods
- Capital calls
- Private-company valuation uncertainty
- IPO timing risk
- Market volatility
- Business execution risk
- Potential fund-tenure extensions
The investor also needs the financial capacity to honour future commitments.
The strategy's private, pre-IPO and listed exposure creates multiple potential return pathways, but it also creates multiple sources of risk.
That trade-off needs to be understood before investing.
The Fund Managers Behind the Carnelian Private Growth & Innovation Fund
Vikas Khemani
Vikas Khemani, CA, CFA, CS, brings 28 years of experience and previously served as CEO at Edelweiss Securities.
His experience spans business incubation, development of businesses into market leaders, structural-theme identification and long-term investing.
His background combines investment-market experience with an entrepreneurial approach to building businesses.
Umesh Agrawal
Umesh Agrawal, CA, also brings 28 years of experience.
He previously served as President & Fund Manager at 360 One Asset and has managed multiple funds across 30 portfolio companies.
His experience includes exits, IRRs and DPI, alongside an earlier investment-banking career involving 90+ deals.
That combination provides exposure to both sides of the transaction:
finding the deal and managing the investment after the deal is done.
The team is also expected to be strengthened by two senior partners.
The Risks Investors Cannot Ignore
The Growth-to-PIPE structure may sound compelling, but alternative investments do not come with guaranteed outcomes.
Private-Market Illiquidity
Growth-stage and pre-IPO investments can take years to monetise.
A business may perform well and still take longer than expected to exit.
Valuation Risk
Private-company valuations can change sharply as earnings, comparable-company valuations and market expectations change.
Buying a great business at an unattractive valuation can still produce disappointing returns.
Execution Risk
Portfolio companies must execute.
Customer concentration, balance-sheet pressure, key-person dependency and operational challenges can affect outcomes.
Governance Risk
Private companies can have complex structures and related-party relationships.
Carnelian's CLEAR framework is designed to identify these issues, but due diligence cannot eliminate every risk.
IPO Risk
Pre-IPO investments depend partly on public-market conditions.
A planned IPO can be delayed, repriced or affected by broader market sentiment.
PIPE Risk
PIPE investments are still exposed to listed-market volatility.
A discounted entry price does not guarantee an attractive exit.
Capital-Call Risk
The initial 10% contribution is only the starting point.
Additional drawdowns can follow as deals are approved.
Extension Risk
The stated tenure can extend by two years, while the commitment period can extend by one year.
Investors therefore need to plan for a potentially longer holding period.
Portfolio Risk
The fund targets 15–20 companies and four or more sectors, but individual investments can still materially influence overall performance.
What About Category II AIF Taxation?
The Carnelian Private Growth strategy is structured within the private-market alternative investment framework, with its formal legal and regulatory terms governed by the applicable fund documentation.
For Category II AIFs, taxation is generally associated with pass-through treatment for eligible investment income, subject to applicable provisions, investor circumstances and prevailing tax regulations.
Actual tax treatment can depend on factors such as:
- Nature of income
- Investor status
- Applicable tax provisions
- Changes in regulations
- Individual circumstances
Investors should therefore review the fund documentation and obtain appropriate tax advice before investing.
The Real Question: Can Carnelian Find Tomorrow's Leaders Before Everyone Else?
That is ultimately the investment thesis.
India has thousands of private businesses backed by institutional capital. Many are growing rapidly. Some will become large public companies. Others will not.
The challenge is identifying the difference before the outcome becomes obvious.
Carnelian's Growth-to-PIPE strategy attempts to solve that challenge through a combination of:
Early-stage access + forensic due diligence + concentrated ownership + active value creation + multiple exit pathways.
The 50–60% growth allocation provides the long-term private-company exposure.
The 20–25% pre-IPO sleeve targets businesses closer to the public markets.
The 20–25% PIPE allocation introduces listed opportunities and is positioned as the strategy's DPI engine.
That combination is what makes the strategy different from a conventional single-stage private-equity approach.
But it also makes the strategy complex.
Carnelian Private Growth & Innovation Fund: The Bottom Line
The most interesting thing about the Carnelian Private Growth & Innovation Fund isn't simply its INR 2,000 crore target.
It is the philosophy behind the capital deployment.
Find the company before the IPO.
Find the growth before the re-rating.
Find the governance transformation before the institutionalisation is complete.
Find the market dislocation when everyone else is focused on the headline.
And then attempt to create value across the entire journey.
The strategy is built for investors who can tolerate illiquidity and long investment horizons in exchange for access to private, pre-IPO and PIPE opportunities.
It has a focused target of 15–20 companies, indicative investments of INR 100–250 crore, exposure across at least four sectors and a stated 15% pre-tax hurdle.
But the opportunity comes with an equally important warning:
Private-market investing can magnify both opportunity and mistakes.
A compelling investment story is not the same thing as a guaranteed return.
For investors considering the Carnelian Private Growth & Innovation Fund, the decision should therefore go beyond asking, “How attractive is the strategy?”
The better question is:
“Can I commit capital for the long term, withstand capital calls and valuation uncertainty, and accept the risks required to potentially participate in India's next generation of market leaders?”
If the answer is yes, the Growth-to-PIPE construct offers a differentiated way to approach India's private-market opportunity.
Need to learn more about the fund? Find complete fund page for Carnelian Private Growth & Innovation.